Florida Senate - 2020                        COMMITTEE AMENDMENT
       Bill No. CS for SB 230
       
       
       
       
       
       
                                Ì638088QÎ638088                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  02/06/2020           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Appropriations (Harrell) recommended the
       following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Between lines 268 and 269
    4  insert:
    5         Section 3. Paragraph (c) of subsection (4) of section
    6  381.915, Florida Statutes, is amended to read:
    7         381.915 Florida Consortium of National Cancer Institute
    8  Centers Program.—
    9         (4) Tier designations and corresponding weights within the
   10  Florida Consortium of National Cancer Institute Centers Program
   11  are as follows:
   12         (c) Tier 3: Florida-based cancer centers seeking
   13  designation as either a NCI-designated cancer center or NCI
   14  designated comprehensive cancer center, which shall be weighted
   15  at 1.0.
   16         1. A cancer center shall meet the following minimum
   17  criteria to be considered eligible for Tier 3 designation in any
   18  given fiscal year:
   19         a. Conducting cancer-related basic scientific research and
   20  cancer-related population scientific research;
   21         b. Offering and providing the full range of diagnostic and
   22  treatment services on site, as determined by the Commission on
   23  Cancer of the American College of Surgeons;
   24         c. Hosting or conducting cancer-related interventional
   25  clinical trials that are registered with the NCI’s Clinical
   26  Trials Reporting Program;
   27         d. Offering degree-granting programs or affiliating with
   28  universities through degree-granting programs accredited or
   29  approved by a nationally recognized agency and offered through
   30  the center or through the center in conjunction with another
   31  institution accredited by the Commission on Colleges of the
   32  Southern Association of Colleges and Schools;
   33         e. Providing training to clinical trainees, medical
   34  trainees accredited by the Accreditation Council for Graduate
   35  Medical Education or the American Osteopathic Association, and
   36  postdoctoral fellows recently awarded a doctorate degree; and
   37         f. Having more than $5 million in annual direct costs
   38  associated with their total NCI peer-reviewed grant funding.
   39         2. The General Appropriations Act or accompanying
   40  legislation may limit the number of cancer centers which shall
   41  receive Tier 3 designations or provide additional criteria for
   42  such designation.
   43         3. A cancer center’s participation in Tier 3 may not extend
   44  beyond June 30, 2024 shall be limited to 6 years.
   45         4. A cancer center that qualifies as a designated Tier 3
   46  center under the criteria provided in subparagraph 1. by July 1,
   47  2014, is authorized to pursue NCI designation as a cancer center
   48  or a comprehensive cancer center until June 30, 2024 for 6 years
   49  after qualification.
   50  
   51  ================= T I T L E  A M E N D M E N T ================
   52  And the title is amended as follows:
   53         Between lines 12 and 13
   54  insert:
   55         amending s. 381.915, F.S.; revising term limits for
   56         Tier 3 cancer center designations within the Florida
   57         Consortium of National Cancer Institute Centers
   58         Program;